LASTACAFT (Page 2 of 2)

17.3 Topical Ophthalmic Use only

For topical ophthalmic administration only.

ALLERGAN
Manufactured for Allergan, Inc., Irvine, CA 92612, U.S.A.
© 2010 Allergan, Inc.
® and ™ marks owned by Allergan, Inc.
Manufactured in the U.S.A. by JHP Pharmaceuticals, LLC

72409US10B

Relabeling and Repackaging by:
Physicians Total Care, Inc., Tulsa, OK 74146

NDC 54868-6294-0

LASTACAFT™

(alcaftadine ophthalmic

solution) 0.25%

3 mL Sterile

LASTACAFT alcaftadine solution/ drops

Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54868-6294(NDC:0023-4290) Route of Administration OPHTHALMIC DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength alcaftadine (alcaftadine) alcaftadine 2.5 mg in 1 mL

Inactive Ingredients Ingredient Name Strength benzalkonium chloride edetate disodium sodium phosphate, monobasic water sodium chloride sodium hydroxide hydrochloric acid

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:54868-6294-0 1 BOTTLE, PLASTIC (1 BOTTLE) in 1 CARTON contains a BOTTLE, PLASTIC 1 3 mL in 1 BOTTLE, PLASTIC This package is contained within the CARTON (54868-6294-0)

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA022134 08/19/2011

Labeler — Physicians Total Care, Inc. (194123980)

Establishment
Name	Address	ID/FEI	Operations
Physicians Total Care, Inc.		194123980	relabel, repack

Revised: 09/2010 Physicians Total Care, Inc.